NYSE:DGXHealthcare
Is Quest Diagnostics (DGX) Still A Bargain Or Fully Priced?
Quest Diagnostics stock has produced strong share price gains in recent years, yet its current US$234.40 price still sits below an intrinsic value estimate from a Discounted Cash Flow (DCF) model that points to meaningful upside.
The stock has returned 87.1% over the past 3 years, which puts recent valuation questions front and center for Quest Diagnostics.
Expectations for steady cash flow generation from diagnostic testing can support the current valuation. At the same time, any pressure...